Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.



from The Medical News http://ift.tt/1H5qN2c